P-441: CGMS in practice: equity, access, and advocacy in Kenya
C LewisAbstract
Introduction
Continuous Glucose Monitoring (CGM) has transformed diabetes care globally, offering real-time insights that improve glycemic control and reduce complications. In Kenya, however, adoption remains limited due to affordability, availability, and policy gaps. This study explores clinical outcomes of CGM use alongside advocacy efforts driving equitable access.
Objectives
To demonstrate how CGMs improve diabetes management in Kenya while highlighting the role of patient-led advocacy in addressing systemic barriers.
Methods
We combined patient case studies, clinician feedback, and advocacy initiatives. Patients using CGMs reported improved confidence, reduced hypoglycemia, and enhanced self-management. Clinicians noted better decision-making and individualized care. Concurrently, advocacy campaigns engaged policymakers and stakeholders to raise awareness, promote affordability, and push for CGM inclusion in national health strategies.
Results
CGM use in Kenya yielded practical benefits: improved HbA1c outcomes, fewer emergency visits, and greater patient empowerment. Advocacy efforts increased awareness among health professionals and policymakers, sparking early discussions on integrating CGMs into broader diabetes care frameworks. The synergy between clinical outcomes and advocacy demonstrated that technology adoption is both a medical and equity issue.
Conclusions
CGMs in practice are transforming diabetes care in Kenya, proving their clinical value while underscoring the urgent need for equitable access. Patient-led advocacy is essential to ensure CGMs become a standard of care rather than a privilege. This case highlights how grassroots voices, combined with clinical evidence, can drive sustainable policy change and improve outcomes for people living with diabetes.